Literature DB >> 5445743

The fate of guanethidine in two hypertensive patients.

C McMartin, R K Rondel, J Vinter, B R Alln, P M Humberstone, A W Leishman, G Sandler, J L Thirkettle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5445743     DOI： 10.1002/cpt1970113423

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

2.  Disposition of guanethidine during chronic oral therapy.

Authors:  J H Hengstmann; F C Falkner
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

Review 3.  Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension.

Authors:  F A Finnerty; R N Brogden
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

4.  Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. II. Oral and rectal administration.

Authors:  J H Jonkman; J Wijsbeek; R A De Zeeuw; L E Van Bork; N G Orie
Journal:  Pharm Weekbl Sci       Date:  1982-10-22

Review 5.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.